Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Uptake, subcellular distribution and biotransformation of 3H-labelled astemizole in cultured rat hepatocytes

Identifieur interne : 000458 ( France/Analysis ); précédent : 000457; suivant : 000459

Uptake, subcellular distribution and biotransformation of 3H-labelled astemizole in cultured rat hepatocytes

Auteurs : Christine Waterkeyn [Belgique] ; Pierre Laduron [Belgique, France] ; Willem Meuldermans [Belgique] ; Andre Trouet [Belgique] ; Yves-Jacques Schneider [Belgique]

Source :

RBID : ISTEX:2EEA4848C2AD32299B6B17BE6126F7912F927A79

English descriptors

Abstract

Abstract: When incubated with3H-astemizole, a potent antagonist of H1 receptor, cultured rat hepatocytes, which do not express specific receptors for this ligand, avidly take up 3H-label proportionally to the drug concentration. HPLC analysis indicates that at 10 ng 3H-astemizole/ml, cells almost entirely deplete the culture medium of the drug within 4 hr of incubation. At 37°, astemizole is metabolized and released into the culture medium mainly under the form of glucuronoconjugated metabolites.Differential centrifugation of homogenates from hepatocytes incubated with 3H-astemizole indicates that astemizole and unconjugated metabolites are found in the particulate fraction, whereas astemizole and conjugated metabolites are present in the cytosol. Isopycnic centrifugation on sucrose gradient shows that the major part of the 3H-label in the particulate fraction distributes like phospholipids and NADPH cytochrome c reductase, suggesting an association with membranes and, in particular, with the endoplasmic reticulum.Chloroquine, a drug accumulating within lysosomes and acidic endosomes, decreases the uptake of 3H-astemizole by hepatocytes and induces, during isopycnic centrifugation of a particulate fraction, a shift of the 3H-label towards lower densities where it closely accompanies cathepsin B. This suggests that a minor part of astemizole accumulated in the hepatocytes could be trapped within lysosomes. These results could support the hypothesis that aspecific binding of astemizole to cellular membranes and, to a lesser extent, trapping in lysosomes could play a role in the pharmacokinetics of the drug.

Url:
DOI: 10.1016/0006-2952(87)90571-5


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:2EEA4848C2AD32299B6B17BE6126F7912F927A79

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Uptake, subcellular distribution and biotransformation of 3H-labelled astemizole in cultured rat hepatocytes</title>
<author>
<name sortKey="Waterkeyn, Christine" sort="Waterkeyn, Christine" uniqKey="Waterkeyn C" first="Christine" last="Waterkeyn">Christine Waterkeyn</name>
</author>
<author>
<name sortKey="Laduron, Pierre" sort="Laduron, Pierre" uniqKey="Laduron P" first="Pierre" last="Laduron">Pierre Laduron</name>
</author>
<author>
<name sortKey="Meuldermans, Willem" sort="Meuldermans, Willem" uniqKey="Meuldermans W" first="Willem" last="Meuldermans">Willem Meuldermans</name>
</author>
<author>
<name sortKey="Trouet, Andre" sort="Trouet, Andre" uniqKey="Trouet A" first="Andre" last="Trouet">Andre Trouet</name>
</author>
<author>
<name sortKey="Schneider, Yves Jacques" sort="Schneider, Yves Jacques" uniqKey="Schneider Y" first="Yves-Jacques" last="Schneider">Yves-Jacques Schneider</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2EEA4848C2AD32299B6B17BE6126F7912F927A79</idno>
<date when="1987" year="1987">1987</date>
<idno type="doi">10.1016/0006-2952(87)90571-5</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-K1N2PJJS-Z/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000B07</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000B07</idno>
<idno type="wicri:Area/Istex/Curation">000B07</idno>
<idno type="wicri:Area/Istex/Checkpoint">002089</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002089</idno>
<idno type="wicri:doubleKey">0006-2952:1987:Waterkeyn C:uptake:subcellular:distribution</idno>
<idno type="wicri:Area/Main/Merge">003402</idno>
<idno type="wicri:Area/Main/Curation">003330</idno>
<idno type="wicri:Area/Main/Exploration">003330</idno>
<idno type="wicri:Area/France/Extraction">000458</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Uptake, subcellular distribution and biotransformation of 3H-labelled astemizole in cultured rat hepatocytes</title>
<author>
<name sortKey="Waterkeyn, Christine" sort="Waterkeyn, Christine" uniqKey="Waterkeyn C" first="Christine" last="Waterkeyn">Christine Waterkeyn</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Université Catholique de Louvain (Unité de Biologie et de Pharmacologie Cellulaire), 75, av. Hippocrate, B-1200 Brussels</wicri:regionArea>
<orgName type="university">Université catholique de Louvain</orgName>
<placeName>
<settlement type="city">Louvain-la-Neuve</settlement>
<region type="region" nuts="1">Région wallonne</region>
<region type="province" nuts="1">Province du Brabant wallon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Laduron, Pierre" sort="Laduron, Pierre" uniqKey="Laduron P" first="Pierre" last="Laduron">Pierre Laduron</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Janssen Pharmaceutica, B-2340 Beerse</wicri:regionArea>
<wicri:noRegion>B-2340 Beerse</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>‡Present address: Rhône Poulenc Santé, Vitry sur Seine</wicri:regionArea>
<wicri:noRegion>Vitry sur Seine</wicri:noRegion>
<wicri:noRegion>Vitry sur Seine</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Meuldermans, Willem" sort="Meuldermans, Willem" uniqKey="Meuldermans W" first="Willem" last="Meuldermans">Willem Meuldermans</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Janssen Pharmaceutica, B-2340 Beerse</wicri:regionArea>
<wicri:noRegion>B-2340 Beerse</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Trouet, Andre" sort="Trouet, Andre" uniqKey="Trouet A" first="Andre" last="Trouet">Andre Trouet</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Université Catholique de Louvain (Unité de Biologie et de Pharmacologie Cellulaire), 75, av. Hippocrate, B-1200 Brussels</wicri:regionArea>
<orgName type="university">Université catholique de Louvain</orgName>
<placeName>
<settlement type="city">Louvain-la-Neuve</settlement>
<region type="region" nuts="1">Région wallonne</region>
<region type="province" nuts="1">Province du Brabant wallon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Schneider, Yves Jacques" sort="Schneider, Yves Jacques" uniqKey="Schneider Y" first="Yves-Jacques" last="Schneider">Yves-Jacques Schneider</name>
<affiliation></affiliation>
<affiliation wicri:level="4">
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Université Catholique de Louvain (Unité de Biologie et de Pharmacologie Cellulaire), 75, av. Hippocrate, B-1200 Brussels</wicri:regionArea>
<orgName type="university">Université catholique de Louvain</orgName>
<placeName>
<settlement type="city">Louvain-la-Neuve</settlement>
<region type="region" nuts="1">Région wallonne</region>
<region type="province" nuts="1">Province du Brabant wallon</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Biochemical Pharmacology</title>
<title level="j" type="abbrev">BCP</title>
<idno type="ISSN">0006-2952</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1987">1987</date>
<biblScope unit="volume">36</biblScope>
<biblScope unit="issue">23</biblScope>
<biblScope unit="page" from="4129">4129</biblScope>
<biblScope unit="page" to="4136">4136</biblScope>
</imprint>
<idno type="ISSN">0006-2952</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0006-2952</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Astemizole</term>
<term>Biochem</term>
<term>Biol</term>
<term>Cathepsin</term>
<term>Centrifugation</term>
<term>Chloroquine</term>
<term>Continuous incubation</term>
<term>Culture medium</term>
<term>Cultured hepatocytes</term>
<term>Cytochrome</term>
<term>Different concentrations</term>
<term>Different durations</term>
<term>Differential centrifugation</term>
<term>Endoplasmic reticulum</term>
<term>Equilibration profile</term>
<term>Experimental protocol</term>
<term>Final supernate</term>
<term>Fresh culture medium</term>
<term>Glucuronoconjugated</term>
<term>Glucuronoconjugated metabolites</term>
<term>Hepatocytes</term>
<term>Homogenate</term>
<term>Hplc analysis</term>
<term>Independent experiments</term>
<term>Isopycnic</term>
<term>Isopycnic centrifugation</term>
<term>Kinetic experiments</term>
<term>Lipophilic</term>
<term>Lower densities</term>
<term>Lysosomal enzymes</term>
<term>Lysosome</term>
<term>Major part</term>
<term>Marker enzyme</term>
<term>Marker enzymes</term>
<term>Metabolite</term>
<term>Nadph</term>
<term>Nadph cytochrome</term>
<term>Native astemizole</term>
<term>Particulate fraction</term>
<term>Phospholipid</term>
<term>Receptor</term>
<term>Reductase</term>
<term>Schneider</term>
<term>Subcellular</term>
<term>Subcellular fractions</term>
<term>Sucrose</term>
<term>Sucrose gradients</term>
<term>Trouet</term>
<term>Unconjugated metabolites</term>
<term>Washout</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: When incubated with3H-astemizole, a potent antagonist of H1 receptor, cultured rat hepatocytes, which do not express specific receptors for this ligand, avidly take up 3H-label proportionally to the drug concentration. HPLC analysis indicates that at 10 ng 3H-astemizole/ml, cells almost entirely deplete the culture medium of the drug within 4 hr of incubation. At 37°, astemizole is metabolized and released into the culture medium mainly under the form of glucuronoconjugated metabolites.Differential centrifugation of homogenates from hepatocytes incubated with 3H-astemizole indicates that astemizole and unconjugated metabolites are found in the particulate fraction, whereas astemizole and conjugated metabolites are present in the cytosol. Isopycnic centrifugation on sucrose gradient shows that the major part of the 3H-label in the particulate fraction distributes like phospholipids and NADPH cytochrome c reductase, suggesting an association with membranes and, in particular, with the endoplasmic reticulum.Chloroquine, a drug accumulating within lysosomes and acidic endosomes, decreases the uptake of 3H-astemizole by hepatocytes and induces, during isopycnic centrifugation of a particulate fraction, a shift of the 3H-label towards lower densities where it closely accompanies cathepsin B. This suggests that a minor part of astemizole accumulated in the hepatocytes could be trapped within lysosomes. These results could support the hypothesis that aspecific binding of astemizole to cellular membranes and, to a lesser extent, trapping in lysosomes could play a role in the pharmacokinetics of the drug.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Belgique</li>
<li>France</li>
</country>
<region>
<li>Province du Brabant wallon</li>
<li>Région wallonne</li>
</region>
<settlement>
<li>Louvain-la-Neuve</li>
</settlement>
<orgName>
<li>Université catholique de Louvain</li>
</orgName>
</list>
<tree>
<country name="Belgique">
<region name="Région wallonne">
<name sortKey="Waterkeyn, Christine" sort="Waterkeyn, Christine" uniqKey="Waterkeyn C" first="Christine" last="Waterkeyn">Christine Waterkeyn</name>
</region>
<name sortKey="Laduron, Pierre" sort="Laduron, Pierre" uniqKey="Laduron P" first="Pierre" last="Laduron">Pierre Laduron</name>
<name sortKey="Meuldermans, Willem" sort="Meuldermans, Willem" uniqKey="Meuldermans W" first="Willem" last="Meuldermans">Willem Meuldermans</name>
<name sortKey="Schneider, Yves Jacques" sort="Schneider, Yves Jacques" uniqKey="Schneider Y" first="Yves-Jacques" last="Schneider">Yves-Jacques Schneider</name>
<name sortKey="Trouet, Andre" sort="Trouet, Andre" uniqKey="Trouet A" first="Andre" last="Trouet">Andre Trouet</name>
</country>
<country name="France">
<noRegion>
<name sortKey="Laduron, Pierre" sort="Laduron, Pierre" uniqKey="Laduron P" first="Pierre" last="Laduron">Pierre Laduron</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000458 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000458 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:2EEA4848C2AD32299B6B17BE6126F7912F927A79
   |texte=   Uptake, subcellular distribution and biotransformation of 3H-labelled astemizole in cultured rat hepatocytes
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021